TL;DR: Non-dilutive funding is capital you raise without giving up equity, board seats, or voting control. It includes grants, R&D tax credits, venture debt, revenue-based financing, SBA loans, and crowdfunding. Most founders underuse it, mainly because the biggest source (the R&D payroll tax credit) doesn't feel like "funding." It shows up as cash you keep instead of cash you raise.
What Is Non-Dilutive Funding?
Non-dilutive funding is any capital a company receives without giving up equity, ownership percentage, or voting control. Your cap table stays exactly as it was before the money arrived. No new shares get issued, nobody gets a board seat, and nobody gets a say in your product roadmap.
That's the core meaning behind the term: "non-dilutive" simply means it doesn't dilute existing shareholders. Compare that to a priced round or a SAFE, where investors receive shares in exchange for capital, and every existing shareholder's percentage ownership shrinks a little.
Non-dilutive funding comes from several distinct sources, each with its own mechanics:
- Federal and state grants (SBIR, STTR, state economic development programs)
- R&D tax credits, including the payroll tax offset
- Venture debt
- Revenue-based financing
- SBA and traditional bank loans
- Reward-based crowdfunding
- Startup competitions and accelerator prizes
Some of these require repayment (loans, venture debt, RBF). Some don't (grants, tax credits, competition winnings). What they share is the one thing that matters most to founders protecting their ownership stake: no equity changes hands.
Dilutive vs. Non-Dilutive Funding
Dilutive funding is any capital raised in exchange for equity: priced rounds, SAFEs, convertible notes, and angel checks. The investor becomes a shareholder, your ownership percentage decreases, and depending on the terms, they may get board representation or veto rights over major decisions.
Non-dilutive funding keeps your cap table untouched. The tradeoff is usually repayment or eligibility requirements instead of ownership.
| Factor | Dilutive Funding | Non-Dilutive Funding |
|---|---|---|
| Ownership impact | Investors receive shares; your percentage decreases | No shares issued; ownership stays the same |
| Control | May include board seats or voting rights | You keep full decision-making control |
| Repayment | Not repaid | Often repaid with interest, or comes with compliance requirements |
| Speed | Typically 3 to 6 months to close | Days to months, depending on the source |
| Best for | Large capital needs, scaling fast | Extending runway, funding R&D, preserving ownership |
Most experienced founders don't pick one or the other. They use non-dilutive sources to stretch runway between equity rounds, fund specific initiatives like R&D, and walk into their next raise with a stronger negotiating position because they need less capital and can wait for better terms.
Types of Non-Dilutive Funding
Grants (SBIR, STTR, and State Programs)
Government grants are the most well-known form of non-dilutive funding, and also the most competitive. The Small Business Innovation Research (SBIR) program and its sister program, Small Business Technology Transfer (STTR), together distribute over $4 billion a year across 11 federal agencies to startups doing R&D-heavy work.
Award sizes vary by agency. Phase I awards generally range from $200,000 to roughly $323,000, and Phase II awards can reach $2 million or more. In 2026, some agencies introduced Strategic Breakthrough Awards that go even higher for specific technology priorities. The application process is demanding, though: expect months of preparation, a detailed technical proposal, and a review process that rejects most applicants for missing the agency's specific solicitation topic rather than for weak science.
Best for: deep tech, biotech, hardware, and any startup solving a technical problem that a federal agency has explicitly prioritized. Many states also run matching grant programs, so it's worth checking your state's economic development office alongside the federal options.
R&D Tax Credits (Including the Payroll Tax Offset)
This is the source most founders underuse, largely because it doesn't feel like "raising funding." It feels like tax paperwork. That's a mistake, because for a pre-revenue or early-revenue startup, it can be the largest non-dilutive cash source available with almost no application risk compared to a grant.
Here's the mechanic: qualified small businesses can apply the federal R&D tax credit against payroll taxes instead of income taxes. That matters because most startups don't owe meaningful income tax in their early years, which makes a standard income tax credit worthless. The payroll tax offset changes that. Every payroll cycle, a company pays 6.2% of wages to Social Security and 1.45% to Medicare. The R&D credit lets qualifying companies offset up to $500,000 of that per year against actual payroll tax liability, real cash that would otherwise leave the bank account every two weeks. Over the 5-year eligibility window, that adds up to as much as $2.5 million in non-dilutive cash.
We've written a full breakdown of how the R&D tax credit payroll offset works after the 2025 OBBBA changes, including which activities qualify and how the immediate expensing rules changed. The short version: if your engineers are solving non-trivial technical problems (not just customizing off-the-shelf software), you likely qualify, and the credit applies whether you're pre-revenue or growing fast.
Best for: any venture-backed or bootstrapped startup with engineering payroll, regardless of industry. Unlike SBIR, there's no topic alignment requirement and no competitive review board. It's a mechanical calculation based on qualifying wages.
Venture Debt
Venture debt is a loan available to companies that have already closed an equity round, typically offered by specialty lenders who work alongside your existing VCs. It's most commonly used to extend runway between rounds, finance equipment, or fund a specific growth initiative without diluting further.
Lenders generally offer one-third to one-half of your most recent equity raise, with repayment terms of 12 to 48 months. One caveat: venture debt often includes warrants, a small equity kicker that gives the lender the right to buy shares later at a fixed price. That makes it mostly non-dilutive rather than purely non-dilutive, so read the term sheet closely.
Best for: VC-backed startups that want extra runway without opening a new equity round.
Revenue-Based Financing (RBF)
Revenue-based financing ties repayment to a percentage of monthly revenue. When revenue is strong, you repay more. When it dips, payments shrink accordingly. Providers connect directly to your financial data (Stripe, your bank account, your accounting software) for fast underwriting, often funding within a week.
You typically repay a fixed total, principal plus a factor rate, so a $100,000 advance at a 1.3x factor rate means repaying $130,000 over time. It's flexible, but it isn't as cheap as a traditional loan.
Best for: SaaS and subscription businesses with predictable, recurring revenue.
SBA and Bank Loans
Traditional bank loans and SBA-backed loans offer fixed monthly payments and predictable terms, usually 3 to 5 years. Lenders look at your balance sheet, income statement, and often your personal credit score. Approval takes longer than RBF or online lending, but qualifying businesses often get lower rates.
Best for: startups with steady revenue, an operating history, and collateral or a strong credit profile.
Crowdfunding
Reward-based crowdfunding, where backers get a product or perk instead of shares, is fully non-dilutive. Equity crowdfunding, through platforms that offer backers actual shares, is dilutive and shouldn't be confused with the reward-based model.
Best for: consumer products with broad appeal, where a campaign doubles as both funding and market validation.
Startup Competitions and Accelerator Prizes
Pitch competitions and awards offer prize money with no repayment or equity required. The dollar amounts are usually smaller than other sources, but the credibility and press coverage that come with winning can open doors that money alone can't.
Best for: early-stage startups with a compelling story and clear vision, especially before you have the traction needed for other non-dilutive sources.
How to Qualify for Non-Dilutive Capital
Qualification varies by source, but a few factors show up across nearly all of them:
- Clean financial records. Lenders and grant reviewers want organized, accurate financial statements. Messy books slow down every application.
- A clear use of funds. Grants and some loans require you to explain exactly how you'll spend the money and what outcome you expect.
- Revenue history, for debt-based sources. RBF and bank loans typically want to see consistent monthly revenue, often with a minimum threshold.
- Qualifying payroll, for the R&D credit. If your team includes engineers solving genuine technical problems, you're likely eligible for the payroll tax offset regardless of revenue stage.
- Topic alignment, for federal grants. SBIR reviewers reject proposals that don't map directly to the agency's published solicitation topic, even when the underlying science is strong.
Common Mistakes Founders Make with Non-Dilutive Funding
- Treating the R&D tax credit as an afterthought. Founders often file for the credit once, a year late, instead of building it into quarterly payroll planning. That delay means real cash sits unclaimed for months.
- Applying to SBIR without reading the actual solicitation. The single most common rejection reason isn't weak technology. It's a proposal that doesn't align paragraph-by-paragraph with the agency's stated topic.
- Ignoring the warrant clause in venture debt term sheets. "Non-dilutive" venture debt can still cost you a small equity stake through warrants. Read the term sheet before assuming it's fully non-dilutive.
- Underestimating compliance overhead on grants. Grants don't require repayment, but they come with reporting requirements and strict rules on how you can use funds. Budget the time, not just the eligibility.
FAQ
Does non-dilutive funding affect my cap table?
No. Non-dilutive funding doesn't issue new shares, so your existing ownership percentages stay exactly the same. That's true whether the source is a grant, a tax credit, or a loan.
Can I combine non-dilutive and dilutive funding?
Yes, and most experienced founders do. A common pattern is to raise a smaller equity round and supplement it with venture debt or R&D tax credits to extend runway while minimizing additional dilution.
Is the R&D tax credit really non-dilutive funding?
Yes. It's cash you keep rather than cash you raise, but the effect on your bank balance and your ownership stake is the same as any other non-dilutive source: real money, no equity given up.
How long does it take to get non-dilutive funding?
It depends entirely on the source. Revenue-based financing can close in days. SBIR grants can take several months from application to disbursement. The R&D payroll tax offset applies each pay period once you've filed, so it's closer to an ongoing cash flow benefit than a one-time infusion.
What companies qualify for non-dilutive capital?
It varies by source. Pre-revenue startups typically have access to grants, competitions, and the R&D tax credit. Once you have consistent revenue, RBF, bank loans, and venture debt (if you're VC-backed) become available too.
